Taj Mohammad Selected Research

Neoplasms (Cancer)

1/2024	Identification of High-Affinity Inhibitors of TANK-Binding Kinase 1 (TBK1): A Promising Frontier for Controlling Inflammatory Signaling in Cancer.
12/2023	Integrated virtual screening and MD simulation study to discover potential inhibitors of Lyn-kinase: targeting cancer therapy.
9/2023	Desmodin and isopongachromene as potential inhibitors of cyclin-dependent kinase 5: phytoconstituents targeting anticancer and neurological therapy.
8/2023	Identification of high-affinity pyridoxal kinase inhibitors targeting cancer therapy: an integrated docking and molecular dynamics simulation approach.
8/2023	Identifying Isoononin and Candidissiol as Rho-associated protein kinase 1 (ROCK1) inhibitors: a combined virtual screening and MD simulation approach.
7/2023	Identification of novel c-Kit inhibitors from natural sources using virtual screening and molecular dynamics simulations.
6/2023	Structure-based identification of potential inhibitors of ribosomal protein S6 kinase 1, targeting cancer therapy: a combined docking and molecular dynamics simulations approach.
6/2023	Identification of natural product-based effective inhibitors of spleen tyrosine kinase (SYK) through virtual screening and molecular dynamics simulation approaches.
7/2022	Inhibiting Cyclin-Dependent Kinase 6 by Taurine: Implications in Anticancer Therapeutics.
6/2022	Discovering Tuberosin and Villosol as Potent and Selective Inhibitors of AKT1 for Therapeutic Targeting of Oral Squamous Cell Carcinoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Taj Mohammad Research Topics

Disease

35	Neoplasms (Cancer) 01/2024 - 02/2018
8	COVID-19 10/2022 - 01/2020
4	Alzheimer Disease (Alzheimer's Disease) 08/2023 - 01/2020
3	Obesity 06/2023 - 12/2021
3	Neoplasm Metastasis (Metastasis) 06/2022 - 02/2020
3	Disease Progression 02/2022 - 01/2021
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2020
3	Infections 02/2021 - 01/2017
3	Carcinogenesis 01/2021 - 01/2020
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 01/2019
2	Squamous Cell Carcinoma of Head and Neck 06/2022 - 05/2022
2	Cataract (Cataracts) 01/2022 - 08/2020
2	Hypertension (High Blood Pressure) 01/2022 - 12/2021
2	Eye Diseases (Eye Disease) 01/2022 - 08/2020
2	Fibrosis (Cirrhosis) 12/2021 - 12/2021
2	Genomic Instability 12/2020 - 01/2019
2	Lung Neoplasms (Lung Cancer) 09/2020 - 05/2020
2	Inflammation (Inflammations) 02/2020 - 02/2018
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2024
1	Heart Neoplasms 11/2023
1	Carcinoma (Carcinomatosis) 08/2023
1	Malaria 08/2023
1	Rheumatoid Arthritis 08/2023
1	Autoimmune Diseases (Autoimmune Disease) 08/2023
1	Diabetes Mellitus 07/2023
1	Hyperglycemia 07/2023
1	Immune System Diseases (Immune Disorders) 02/2022
1	Mouth Neoplasms (Oral Cancer) 01/2022
1	Neuroblastoma 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2022
1	Liver Neoplasms (Liver Cancer) 12/2021
1	Diabetic Nephropathies (Diabetic Nephropathy) 12/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2021

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 07/2023 - 05/2018
11	Phosphotransferases (Kinase)IBA 01/2024 - 02/2018
5	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 02/2021 - 07/2019
5	sphingosine kinaseIBA 09/2020 - 10/2019
4	Rivastigmine (Exelon)FDA LinkGeneric 03/2021 - 01/2019
4	tartaric acid (tartrate)FDA Link 03/2021 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2022
3	QuercetinIBA 01/2022 - 09/2019
3	Pyruvic Acid (Pyruvate)IBA 02/2021 - 07/2019
3	Peptide Hydrolases (Proteases)FDA Link 02/2021 - 01/2021
3	EnzymesIBA 01/2021 - 10/2019
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2023 - 01/2022
2	Protein Kinases (Protein Kinase)IBA 08/2023 - 09/2021
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 06/2022 - 01/2021
2	Crystallins (Crystallin)IBA 01/2022 - 08/2020
2	RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA 01/2021 - 01/2021
2	SARS-CoV-2 3C-like proteinaseIBA 10/2020 - 01/2020
2	Transferrin (beta 2 Transferrin)IBA 01/2020 - 01/2019
1	PyridoxalIBA 08/2023
1	Pyridoxal KinaseIBA 08/2023
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 08/2023
1	bacopaside IIIBA 08/2023
1	quinolineIBA 08/2023
1	tau Proteins (tau Protein)IBA 08/2023
1	FructoseIBA 07/2023
1	Insulin (Novolin)FDA Link 07/2023
1	hecogeninIBA 06/2023
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 06/2023
1	glabreneIBA 06/2023
1	Syk KinaseIBA 06/2023
1	PhytochemicalsIBA 06/2023
1	Protein Kinase InhibitorsIBA 06/2023
1	Taurine FDA Link 07/2022
1	CyclinsIBA 07/2022
1	Cyclin-Dependent Kinase 6IBA 07/2022
1	villosolIBA 06/2022
1	tuberosinIBA 06/2022
1	Casein Kinase II (Casein Kinase 2)IBA 03/2022
1	Protein Deglycase DJ-1IBA 02/2022
1	Insulin ReceptorIBA 01/2022
1	HexokinaseIBA 01/2022
1	thymoquinoneIBA 01/2022
1	alpha-Crystallins (alpha-Crystallin)IBA 01/2022
1	Anaplastic Lymphoma KinaseIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	RotenoneIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Death-Associated Protein KinasesIBA 01/2022
1	polyethylene glycol 400IBA 01/2022
1	cinnamaldehyde (cinnamic aldehyde)FDA Link 01/2022
1	KetanserinIBA 01/2022
1	ElementsIBA 12/2021
1	GlucocorticoidsIBA 12/2021
1	LipidsIBA 12/2021
1	SterolsIBA 12/2021
1	Small Interfering RNA (siRNA)IBA 12/2021
1	Sterol Regulatory Element Binding ProteinsIBA 12/2021
1	Aurora Kinase BIBA 08/2021
1	Multifunctional EnzymesIBA 02/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	NucleotidesIBA 01/2021
1	Serine (L-Serine)FDA Link 01/2021

Therapy/Procedure

33	Therapeutics 12/2023 - 02/2018
1	Unani Medicine 10/2022